ID   DDX43_HUMAN             Reviewed;         648 AA.
AC   Q9NXZ2; B4E0C8; Q6NXR1;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   28-JUN-2023, entry version 171.
DE   RecName: Full=Probable ATP-dependent RNA helicase DDX43;
DE            EC=3.6.4.13;
DE   AltName: Full=Cancer/testis antigen 13;
DE            Short=CT13;
DE   AltName: Full=DEAD box protein 43;
DE   AltName: Full=DEAD box protein HAGE;
DE   AltName: Full=Helical antigen;
GN   Name=DDX43; Synonyms=HAGE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS GLU-625 AND ARG-629, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10919659;
RA   Martelange V.M.F., De Smet C., De Plaen E., Lurquin C., Boon T.;
RT   "Identification on a human sarcoma of two new genes with tumor-specific
RT   expression.";
RL   Cancer Res. 60:3848-3855(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLU-625
RP   AND ARG-629.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- INTERACTION:
CC       Q9NXZ2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-10316543, EBI-3867333;
CC       Q9NXZ2; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-10316543, EBI-10171774;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NXZ2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NXZ2-2; Sequence=VSP_056955, VSP_056956;
CC   -!- TISSUE SPECIFICITY: Expressed in testis. Expressed in many tumors of
CC       various histological types at a level that is 100-fold higher than the
CC       level observed in normal tissues except testis.
CC       {ECO:0000269|PubMed:10919659}.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/40288/DDX43";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ278110; CAB92442.1; -; mRNA.
DR   EMBL; AL136751; CAB66685.1; -; mRNA.
DR   EMBL; AK303324; BAG64390.1; -; mRNA.
DR   EMBL; AC019205; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066938; AAH66938.1; -; mRNA.
DR   CCDS; CCDS4977.1; -. [Q9NXZ2-1]
DR   RefSeq; NP_061135.2; NM_018665.2. [Q9NXZ2-1]
DR   AlphaFoldDB; Q9NXZ2; -.
DR   SMR; Q9NXZ2; -.
DR   BioGRID; 120690; 21.
DR   IntAct; Q9NXZ2; 6.
DR   MINT; Q9NXZ2; -.
DR   STRING; 9606.ENSP00000359361; -.
DR   GlyGen; Q9NXZ2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NXZ2; -.
DR   PhosphoSitePlus; Q9NXZ2; -.
DR   BioMuta; DDX43; -.
DR   DMDM; 145559466; -.
DR   EPD; Q9NXZ2; -.
DR   MassIVE; Q9NXZ2; -.
DR   MaxQB; Q9NXZ2; -.
DR   PaxDb; Q9NXZ2; -.
DR   PeptideAtlas; Q9NXZ2; -.
DR   ProteomicsDB; 5666; -.
DR   ProteomicsDB; 83146; -. [Q9NXZ2-1]
DR   Antibodypedia; 31333; 159 antibodies from 25 providers.
DR   DNASU; 55510; -.
DR   Ensembl; ENST00000370336.5; ENSP00000359361.4; ENSG00000080007.8. [Q9NXZ2-1]
DR   GeneID; 55510; -.
DR   KEGG; hsa:55510; -.
DR   MANE-Select; ENST00000370336.5; ENSP00000359361.4; NM_018665.3; NP_061135.2.
DR   UCSC; uc003pgw.4; human. [Q9NXZ2-1]
DR   AGR; HGNC:18677; -.
DR   CTD; 55510; -.
DR   DisGeNET; 55510; -.
DR   GeneCards; DDX43; -.
DR   HGNC; HGNC:18677; DDX43.
DR   HPA; ENSG00000080007; Group enriched (placenta, testis).
DR   MIM; 606286; gene.
DR   neXtProt; NX_Q9NXZ2; -.
DR   OpenTargets; ENSG00000080007; -.
DR   PharmGKB; PA134988734; -.
DR   VEuPathDB; HostDB:ENSG00000080007; -.
DR   eggNOG; KOG0336; Eukaryota.
DR   GeneTree; ENSGT00940000164259; -.
DR   HOGENOM; CLU_003041_16_8_1; -.
DR   InParanoid; Q9NXZ2; -.
DR   OMA; GESITFM; -.
DR   OrthoDB; 5477821at2759; -.
DR   PhylomeDB; Q9NXZ2; -.
DR   TreeFam; TF312949; -.
DR   PathwayCommons; Q9NXZ2; -.
DR   SignaLink; Q9NXZ2; -.
DR   BioGRID-ORCS; 55510; 15 hits in 1148 CRISPR screens.
DR   ChiTaRS; DDX43; human.
DR   GeneWiki; DDX43; -.
DR   GenomeRNAi; 55510; -.
DR   Pharos; Q9NXZ2; Tbio.
DR   PRO; PR:Q9NXZ2; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9NXZ2; protein.
DR   Bgee; ENSG00000080007; Expressed in oocyte and 113 other tissues.
DR   Genevisible; Q9NXZ2; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0003724; F:RNA helicase activity; IBA:GO_Central.
DR   CDD; cd17958; DEADc_DDX43_DDX53; 1.
DR   CDD; cd22430; KH-I_DDX43_DDX53; 1.
DR   CDD; cd18787; SF2_C_DEAD; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   PANTHER; PTHR47958; ATP-DEPENDENT RNA HELICASE DBP3; 1.
DR   PANTHER; PTHR47958:SF17; ATP-DEPENDENT RNA HELICASE DDX43-RELATED; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00013; KH_1; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SMART; SM00322; KH; 1.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Helicase; Hydrolase; Nucleotide-binding;
KW   Reference proteome; RNA-binding.
FT   CHAIN           1..648
FT                   /note="Probable ATP-dependent RNA helicase DDX43"
FT                   /id="PRO_0000054972"
FT   DOMAIN          67..128
FT                   /note="KH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          273..448
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          460..621
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          628..648
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           242..270
FT                   /note="Q motif"
FT   MOTIF           396..399
FT                   /note="DEAD box"
FT   BINDING         286..293
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   VAR_SEQ         190..195
FT                   /note="DLPPIK -> GKKILI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056955"
FT   VAR_SEQ         196..648
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056956"
FT   VARIANT         625
FT                   /note="K -> E (in dbSNP:rs311686)"
FT                   /evidence="ECO:0000269|PubMed:10919659,
FT                   ECO:0000269|PubMed:11230166"
FT                   /id="VAR_057234"
FT   VARIANT         629
FT                   /note="Q -> R (in dbSNP:rs311685)"
FT                   /evidence="ECO:0000269|PubMed:10919659,
FT                   ECO:0000269|PubMed:11230166"
FT                   /id="VAR_057235"
FT   CONFLICT        60
FT                   /note="A -> D (in Ref. 5; AAH66938)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   648 AA;  72844 MW;  4E09F15D36EFC3E3 CRC64;
     MSHHGGAPKA STWVVASRRS STVSRAPERR PAEELNRTGP EGYSVGRGGR WRGTSRPPEA
     VAAGHEELPL CFALKSHFVG AVIGRGGSKI KNIQSTTNTT IQIIQEQPES LVKIFGSKAM
     QTKAKAVIDN FVKKLEENYN SECGIDTAFQ PSVGKDGSTD NNVVAGDRPL IDWDQIREEG
     LKWQKTKWAD LPPIKKNFYK ESTATSAMSK VEADSWRKEN FNITWDDLKD GEKRPIPNPT
     CTFDDAFQCY PEVMENIKKA GFQKPTPIQS QAWPIVLQGI DLIGVAQTGT GKTLCYLMPG
     FIHLVLQPSL KGQRNRPGML VLTPTRELAL QVEGECCKYS YKGLRSVCVY GGGNRDEQIE
     ELKKGVDIII ATPGRLNDLQ MSNFVNLKNI TYLVLDEADK MLDMGFEPQI MKILLDVRPD
     RQTVMTSATW PHSVHRLAQS YLKEPMIVYV GTLDLVAVSS VKQNIIVTTE EEKWSHMQTF
     LQSMSSTDKV IVFVSRKAVA DHLSSDLILG NISVESLHGD REQRDREKAL ENFKTGKVRI
     LIATDLASRG LDVHDVTHVY NFDFPRNIEE YVHRIGRTGR AGRTGVSITT LTRNDWRVAS
     ELINILERAN QSIPEELVSM AERFKAHQQK REMERKMERP QGRPKKFH
//
